Real compensation ranges by study type, what makes the number go up or down, and how and when the money actually arrives.
Most paid clinical trials in the United States pay between $75 and $4,500 per completed study, based on industry-wide study data. The single biggest factor is the study type: a short observational study might pay $25 to $100 per visit, while the median Phase 1 study for healthy volunteers pays around $3,070. Long inpatient studies with multiple overnight stays can exceed $10,000 in rare cases.
Compensation is not a salary and it is not payment for taking risk. Research sites frame it as payment for your time, inconvenience, and travel. That distinction matters legally and it also explains the math: the more of your time a study takes, the more it pays. This guide breaks down the ranges, the variables, and the payment mechanics so you know what a fair offer looks like.
The table below reflects common ranges across US research sites. Individual studies can fall outside these bands, but if an ad promises far more for far less commitment, treat it as a red flag.
| Study type | Typical compensation | Time commitment |
|---|---|---|
| Observational study (surveys, records, samples) | $25–$100 per visit | Short visits, low burden |
| Outpatient drug study (Phase 2–3) | $75–$1,500 per study | Multiple clinic visits over weeks or months |
| Vaccine trial | $50–$150 per visit plus completion bonus | Several visits plus follow-up calls |
| Phase 1 healthy volunteer study | Median around $3,070 | Screening plus confinement and follow-ups |
| Long inpatient study with overnight stays | $4,500 to $10,000+ (rare) | One or more multi-night confinement periods |
Where you live matters too, because study density varies by metro. Hubs like Dallas and Los Angeles have multiple dedicated Phase 1 units, which is where the higher-paying studies concentrate.
Sites calculate compensation from the study protocol before recruitment starts, and an IRB (Institutional Review Board) reviews the amount to make sure it is not coercive. The main drivers:

Payment schedules are spelled out in the informed consent document before you enroll — read that section carefully. Two models dominate:
Per completed visit. Most outpatient studies pay a fixed amount after each visit, loaded onto a reloadable prepaid debit card or sent by direct deposit or check. If you withdraw halfway, you keep what you earned for completed visits. Federal guidance discourages designs that withhold everything until the end.
Per visit plus completion bonus. Many studies add a bonus for finishing all visits. The bonus rewards completion but the per-visit portion is yours regardless. Prepaid cards typically load within days of each visit; checks can take a few weeks.
You can withdraw from any study at any time without penalty beyond forfeiting future visit payments. That right is non-negotiable in any legitimate, IRB-supervised study.
Separate from compensation, many studies reimburse out-of-pocket costs: mileage or rideshare fares, parking, meals during long visits, and occasionally hotel nights for participants traveling to a distant site. Reimbursements are common and worth asking about during the pre-screen call, because they are not always advertised.
The distinction between compensation and reimbursement also matters at tax time. Compensation is generally taxable income, and research sites issue a 1099-MISC if they pay you more than $600 in a year. Documented expense reimbursements are treated differently. The full breakdown is in our guide to clinical trial payments and taxes — and for anything specific to your situation, consult a tax professional.
Join the free email alert — we watch the NIH registry weekly so you don't have to.
Get trial alertsA few honest caveats. First, high-paying studies are competitive: dedicated Phase 1 units maintain volunteer databases and screening failure is routine, so the advertised amount is not guaranteed income. Second, washout rules — typically 30 days minimum between studies, often more — cap how often you can participate. Frequent volunteers realistically complete one or two studies per year, which makes this meaningful side income, not a living.
Third, participation itself is always free. You never pay to join, and any site asking for money, gift cards, or your bank login before screening is not running a legitimate study. Every real trial is registered on ClinicalTrials.gov, the NIH registry, and you can look up its identifier yourself. If the top of the pay range is what interests you, read our breakdown of the highest paid clinical trials next.
A useful habit when comparing listings: divide the total compensation by the hours the protocol actually asks of you, including travel and screening. Two studies advertising the same total can differ enormously once you count the visits, and the hourly view is what separates a genuinely good study from one that merely has a big headline number.
Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.